SEC EDGAR · Company announcement
SNPS: Material agreement · Leadership change · Company disclosure
Filed 8-K for an event or period dated 2026-05-26. Material agreement; Leadership change; Company disclosure.
Follow SNPS- Became public
- May 27, 2026, 4:15 PM EDT
- Event / period date
- May 26, 2026
- Collected
- Nov 10, 2026, 8:37 AM EST
Why this is connected
This filing identifies SYNOPSYS INC as the issuer of the security. The company's SEC identifier connects it to SNPS.
Press Release dated May 27, 2026 announcing the appointment of Jesse Cohn to the Board of Directors of Synopsys, Inc. ↗Source evidence
Read the source excerpt or record
Item 1.01. Entry into a Material Definitive Agreement. On May 26, 2026, Synopsys, Inc. (“ Synopsys ”) entered into a Cooperation Agreement (the “ Agreement ”) with Elliott Investment Management L.P., Elliott Associates, L.P. and Elliott International, L.P. (collectively, “ Elliott ”). Pursuant to the Agreement, the Board of Directors of Synopsys (the “ Board ”) agreed to increase the size of the Board by one, appoint Jesse Cohn to the Board, effective as of June 1, 2026 (the “ Effective Date ”), with an initial term expiring at Synopsys’ 2027 annual meeting of stockholders (the “ 2027 Annual Meeting ”). The Board also agreed to appoint Mr. Cohn to the Corporate Governance and Nominating Committee of the Board and include Mr. Cohn in Synopsys’ slate of nominees for election at the 2027 Annual Meeting. In connection with his appointment to the Board, the Board determined that Mr. Cohn qualified as an independent director under the listing rules of The Nasdaq Stock Market and the rules and regulations of the U.S. Securities Exchange Act of 1934, as amended (the “ Exchange Act ”). The Agreement further provides that in the event that Mr. Cohn is unable or unwilling to serve as a director, resigns as a director, is removed as a director or ceases to be a director for any other reason prior to the expiration of the Cooperation Period (as defined below), Synopsys and Elliott will cooperate in good faith to mutually select a substitute director to serve as a director of Synopsys for the remainder of Mr. Cohn’s term (the “ Replacement Director ”), provided that at such time Elliott beneficially owns a “net-long position” of, or has aggregate net-long economic exposure to, at least 1.5% of Synopsys’ then-outstanding common stock. The Agreement also includes certain voting commitm
Congressional trading in SNPS
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 12, 2026 · disclosed Nov 5, 2026 · Spouse
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
- May 11, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Apr 13, 2026 · disclosed May 11, 2026 · Spouse
- Feb 6, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Jan 13, 2026 · disclosed Feb 6, 2026 · Spouse
- Jan 15, 2026$1K–$15K
Rep. Dan Newhouse (R-WA-4)
$1K–$15K · Traded Dec 31, 2025 · disclosed Jan 15, 2026 · Spouse
- Dec 15, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Nov 18, 2025 · disclosed Dec 15, 2025
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.